-
1
-
-
0034511971
-
Urticarial venulitis
-
Soter NA. Urticarial venulitis. Dermatol Ther 2000;13:400-8.
-
(2000)
Dermatol Ther
, vol.13
, pp. 400-408
-
-
Soter, N.A.1
-
2
-
-
0015874635
-
Hypocomplementemia with cutaneous vasculitis and arthritis: Possible immune complex syndrome
-
McDuffie FC, Sams WM Jr, Maldonado JE, Audreini PH, Samayoa EA. Hypocomplementemia with cutaneous vasculitis and arthritis: possible immune complex syndrome. Mayo Clin Proc 1973;48:340-8.
-
(1973)
Mayo Clin Proc
, vol.48
, pp. 340-348
-
-
McDuffie, F.C.1
Sams W.M., Jr.2
Maldonado, J.E.3
Audreini, P.H.4
Samayoa, E.A.5
-
4
-
-
0021906865
-
Urticarial vasculitis
-
Gammon WR. Urticarial vasculitis. Dermatol Clin 1985;3:97-105.
-
(1985)
Dermatol Clin
, vol.3
, pp. 97-105
-
-
Gammon, W.R.1
-
5
-
-
0025362134
-
Urticarial vasculitis associated with a monoclonal IgM gammopathy: Schnitzler's syndrome
-
Borradori L, Rybojad M, Puissant A, Dallot A, Verola O, Morel P. Urticarial vasculitis associated with a monoclonal IgM gammopathy: Schnitzler's syndrome. Br J Dermatol 1990;123:113-8.
-
(1990)
Br J Dermatol
, vol.123
, pp. 113-118
-
-
Borradori, L.1
Rybojad, M.2
Puissant, A.3
Dallot, A.4
Verola, O.5
Morel, P.6
-
6
-
-
0018989477
-
Urticarial vasculitis and IgA myeloma
-
Highet AS. Urticarial vasculitis and IgA myeloma. Br J Dermatol 1980;102:355-7.
-
(1980)
Br J Dermatol
, vol.102
, pp. 355-357
-
-
Highet, A.S.1
-
7
-
-
0028854458
-
Hypocomplementemic urticarial vasculitis syndrome: Clinical and serologic findings in 18 patients
-
Wisnieski JJ, Baer AN, Chistensen J, Cupps TR, Flagg DN, Verrier Jones J, et al. Hypocomplementemic urticarial vasculitis syndrome: clinical and serologic findings in 18 patients. Medicine 1985;74:24-41.
-
(1985)
Medicine
, vol.74
, pp. 24-41
-
-
Wisnieski, J.J.1
Baer, A.N.2
Chistensen, J.3
Cupps, T.R.4
Flagg, D.N.5
Verrier Jones, J.6
-
8
-
-
0142242663
-
Efficacy of hydroxychloroquine treatment of urticarial vasculitis
-
Curd JG, Zuraw BL. Efficacy of hydroxychloroquine treatment of urticarial vasculitis. J Allergy Clin Immunol 1984;73:181.
-
(1984)
J Allergy Clin Immunol
, vol.73
, pp. 181
-
-
Curd, J.G.1
Zuraw, B.L.2
-
10
-
-
0029920574
-
Mechanisms of action of IVIG in immune-mediated disease
-
Mouthon L, Kaveri SV. Mechanisms of action of IVIG in immune-mediated disease. Clin Exp Immunol 1996;104:3-9.
-
(1996)
Clin Exp Immunol
, vol.104
, pp. 3-9
-
-
Mouthon, L.1
Kaveri, S.V.2
-
11
-
-
0033577903
-
A novel mouse with B cells but lacking, serum antibody reveals antibody-independent role for B cells in murine lupus
-
Chan OTM, Hannum LG. A novel mouse with B cells but lacking, serum antibody reveals antibody-independent role for B cells in murine lupus. J Exp Med 1999;189:1639-47.
-
(1999)
J Exp Med
, vol.189
, pp. 1639-1647
-
-
Chan, O.T.M.1
Hannum, L.G.2
-
12
-
-
0034669990
-
Disturbed peripheral B lymphocyte homeostasis in SLE
-
Odendahle M, Jacobi A. Disturbed peripheral B lymphocyte homeostasis in SLE. J Immunol 2000;165:5970-9.
-
(2000)
J Immunol
, vol.165
, pp. 5970-5979
-
-
Odendahle, M.1
Jacobi, A.2
-
13
-
-
0033230622
-
Clinical applications of anti-CD20 antibodies
-
Gopal AK, Press OW. Clinical applications of anti-CD20 antibodies. J Lab Clin Med 1999;134:445-50.
-
(1999)
J Lab Clin Med
, vol.134
, pp. 445-450
-
-
Gopal, A.K.1
Press, O.W.2
-
14
-
-
0034940321
-
Treatment of refractory autoimmune hemolytic anemia with anti-CD20
-
Ahrens N, Kingreen D. Treatment of refractory autoimmune hemolytic anemia with anti-CD20. Br J Hematol 2001;114:244-5.
-
(2001)
Br J Hematol
, vol.114
, pp. 244-245
-
-
Ahrens, N.1
Kingreen, D.2
-
15
-
-
85058722231
-
Phase I/II open-label, dose-escalation trial of rituximab in patients with SLE
-
Anolik JH, Campbell D. Phase I/II open-label, dose-escalation trial of rituximab in patients with SLE. J Invest Med 2001;49:151a.
-
(2001)
J Invest Med
, vol.49
-
-
Anolik, J.H.1
Campbell, D.2
|